Ask AI
ProCE Banner Series

Optimizing Antimicrobial Management and Tackling Resistance in Gram-Negative HAP/VAP Infections

In this live symposium, expert faculty will share insights on strategies to optimize early effective antimicrobial therapy for treatment of HAP/VAP while considering risk for antimicrobial resistance and patient-specific factors through case-based discussion.

Join us from 11:45 AM -12:00 PM Eastern Time (ET) for in-person registration or at 12:00 PM ET online when the symposium beings. This symposium is being held during the MAD-ID 2023 Annual Meeting.

  AMA
  | ACPE-P
Credits Available

1.5

Who Should Attend

The target audience for this activity is physicians, pharmacists, and other healthcare professionals caring for patients with suspected or documented antimicrobial resistant nosocomial pneumonia.

All Events

Optimizing Antimicrobial Management and Tackling Resistance in Gram-Negative HAP/VAP Infections

Past Events

May

12

2023

12:00 PM - 1:30 PM Eastern Time (ET)

In-personVirtual

Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida 32819

Topics

Optimizing Antimicrobial Management and Tackling Resistance in Gram-Negative HAP/VAP Infections

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of healthcare professionals in improving antimicrobial management of HAP/VAP and outcomes for patients with suspected or documented antimicrobial resistance. 

Target Audience
The target audience for this activity is physicians, pharmacists, and other healthcare professionals caring for patients with suspected or documented antimicrobial resistant nosocomial pneumonia. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess phenotypic susceptibility patterns and molecular resistance of gram-negative pathogens to determine appropriate antimicrobial therapy
  • Compare available antimicrobial agents for HAP/VAP caused by difficult-to-treat gram-negative pathogens
  • Incorporate guidelines, patient-specific factors, and laboratory data into the selection of optimal treatment regimens for patients with known or suspect antimicrobial resistant gram-negative infections

Accreditation

CE Accreditation

Pharmacists

This activity is jointly provided by ProCE, LLC, Clinical Care Options, LLC, and the Society of Infectious Diseases Pharmacists (SIDP).  ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-014-L01-P has been assigned to this live application-based activity (initial release date 05/12/2023). This activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC and Society of Infectious Diseases Pharmacists (SIDP).   Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure
ProCE, LLC and Clinical Care Options, LLC (CCO) require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE and CCO policy. ProCE and CCO are committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by ProCE, LLC and Clinical Care Options LLC, in partnership with the Society of Infectious Diseases Pharmacists (SIDP).

Supported by an educational grant from Merck Sharp & Dohme LLC.

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191